Satomi Yogosawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
DYRK2 promotes chemosensitivity via p53-mediated apoptosis after DNA damage in colorectal cancer.
Journal: Cancer science
Published: June 02, 2023
Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras.
Journal: JHEP reports : innovation in hepatology
Published: October 21, 2022
Carbonic anhydrase 13 suppresses bone metastasis in breast cancer.
Journal: Cancer treatment and research communications
Published: December 22, 2020
PKCδ deficiency inhibits fetal development and is associated with heart elastic fiber hyperplasia and lung inflammation in adult PKCδ knockout mice.
Journal: PloS one
Published: December 08, 2020
The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis.
Journal: eLife
Published: March 30, 2020
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells.
Journal: Scientific reports
Published: May 19, 2019
Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
Journal: Cancer letters
Published: November 02, 2018
Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis.
Journal: Cancer science
Published: May 29, 2018
Downregulation of CD24 suppresses bone metastasis of lung cancer.
Journal: Cancer science
Published: June 21, 2017
A Novel Near-infrared Fluorescent Protein, iRFP720, Facilitates Transcriptional Profiling of Prostate Cancer Bone Metastasis in Mice.
Journal: Anticancer research
Published: April 11, 2017
Last Updated: 09/26/2026